The BioPharm Brief: Trials Test CAR-T, Immunology and Targeted Oncology

Oct 12, 08:18 PM
Headliner
Share
Subscribe

Welcome to The BioPharm Brief, your daily snapshot of the latest developments shaping biopharmaceutical research, clinical progress, and regulatory strategy. Today’s update explores experimental cell therapies for brain tumors, a combination approach for ulcerative colitis, mixed results in a rare bone disease, and a late-stage radiopharmaceutical trial success in neuroendocrine tumors.

Share
Subscribe
Next
The BioPharm Brief: Trials Expand Cancer, Eye Disease and Obesity Care
Top episodes
The BioPharm Brief: Early Design Risks, Oncology Signals, and a Biosimilars Power Move
by The BioPharm Brief
The BioPharm Brief: Cancer, Personalized
by The BioPharm Brief
The BioPharm Brief: What’s the Big Deal About Multispecific T-Cell Engagers in Cancer and Autoimmune Diseases?
by The BioPharm Brief